Biomedical Engineering Reference
In-Depth Information
[40]
Niehues, T., Reichenbach, J., Neubert, J.
et al., Nuclear factor kappaB essential
modulator-deficient child with immunodeficiency yet without anhidrotic ectodermal
dysplasia,
J. Allergy Clin. Immunol.,
114, 1456, 2004.
[41]
Courtois, G., Smahi, A., Reichenbach, J.
et al., A hypermorphic IκBα mutation is
associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell
immunodeficiency,
J. Clin. Invest.,
112, 1108, 2003.
[42]
Janssen, R., van Wengen, A., Hoeve, M.A.
et al., The same IκBα mutation in two
related individuals leads to completely different clinical syndromes,
J. Exp. Med.,
200, 559, 2004.
[43]
Trompouki, E., Hatzivassiliou, E., Tsichritzis, T.
et al., CYLD is a deubiquitinating
enzyme that negatively regulates NF-κB activation by TNFR family members,
Nature,
424, 793, 2003.
[44]
Kovalenko, A., Chable-Bessia, C., Cantarella, G.
et al., The tumour suppressor CYLD
negatively regulates NF-kappaB signalling by deubiquitination,
Nature,
424, 801,
2003.
[45]
Brummelkamp, T.R., Nijman, S.M., Dirac, A.M.
et al., Loss of the cylindromatosis
tumour suppressor inhibits apoptosis by activating NF-κB,
Nature,
424, 797, 2003.
[46]
Bignell, G.R., Warren, W., Seal, S.
et al., Identification of the familial cylindromatosis
tumour-suppressor gene,
Nature Genet.,
25, 160, 2000.
[47]
Jono, H., Lim, J.H., Chen, L.F.
et al., NF-kappaB is essential for induction of CYLD,
the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory
feedback pathway,
J. Biol. Chem.,
279, 36171, 2004.
[48]
Reiley, W., Zhang, M., and Sun, S.C., Negative regulation of JNK signaling pathway
by the tumor suppressor CYLD,
J. Biol. Chem.,
279, 55161, 2004.
